CASP10

Chr 2AD

caspase 10

Also known as: ALPS2, FLICE-2, FLICE2, MCH4

This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 3 and 7, and the protein itself is processed by caspase 8. Mutations in this gene are associated with type IIA autoimmune lymphoproliferative syndrome, non-Hodgkin lymphoma and gastric cancer. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]

Primary Disease Associations & Inheritance

Autoimmune lymphoproliferative syndrome, type IIMIM #603909
AD
Gastric cancer, somaticMIM #613659
Lymphoma, non-Hodgkin, somaticMIM #605027
UniProtFamilial non-Hodgkin lymphoma
579
ClinVar variants
29
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummaryCASP10
🧬
Gene-Disease Validity (ClinGen)
autoimmune lymphoproliferative syndrome type 2A · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
29 Pathogenic / Likely Pathogenic· 335 VUS of 579 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
1.29LOEUF
pLI 0.000
Z-score 0.53
OE 0.88 (0.611.29)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
0.03Z-score
OE missense 1.00 (0.901.10)
271 obs / 272.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.88 (0.611.29)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.1.00 (0.901.10)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.03
01.21.6
LoF obs/exp: 19 / 21.7Missense obs/exp: 271 / 272.2Syn Z: -0.23

ClinVar Variant Classifications

579 submitted variants in ClinVar

Classification Summary

Pathogenic27
Likely Pathogenic2
VUS335
Likely Benign147
Benign58
Conflicting10
27
Pathogenic
2
Likely Pathogenic
335
VUS
147
Likely Benign
58
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
1
24
0
27
Likely Pathogenic
1
0
1
0
2
VUS
20
239
73
3
335
Likely Benign
1
5
54
87
147
Benign
0
3
53
2
58
Conflicting
10
Total2424820592579

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CASP10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

CASP10-related autoimmune lymphoproliferative syndrome

strong
ADDominant NegativeAltered Gene Product Structure
Skin
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Autoimmune lymphoproliferative syndrome, type II

MIM #603909

Molecular basis of disorder known

Autosomal dominant

Gastric cancer, somatic

MIM #613659

Molecular basis of disorder known

Lymphoma, non-Hodgkin, somatic

MIM #605027

Molecular basis of disorder known

📖
GeneReview available — CASP10
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →